- Home
- ACB vs MASS Comparison
ACB vs MASS Comparison
Compare ACB & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACB
- MASS
- Stock Information
- Founded
- ACB 2013
- MASS 2012
- Country
- ACB Canada
- MASS United States
- Employees
- ACB N/A
- MASS N/A
- Industry
- ACB Pharmaceuticals and Biotechnology
- MASS Medical/Dental Instruments
- Sector
- ACB Health Care
- MASS Health Care
- Exchange
- ACB Nasdaq
- MASS Nasdaq
- Market Cap
- ACB 256.5M
- MASS 235.8M
- IPO Year
- ACB N/A
- MASS 2020
- Fundamental
- Price
- ACB $4.99
- MASS $6.53
- Analyst Decision
- ACB
- MASS Strong Buy
- Analyst Count
- ACB 0
- MASS 3
- Target Price
- ACB N/A
- MASS $8.00
- AVG Volume (30 Days)
- ACB 1.1M
- MASS 276.7K
- Earning Date
- ACB 11-05-2025
- MASS 11-11-2025
- Dividend Yield
- ACB N/A
- MASS N/A
- EPS Growth
- ACB N/A
- MASS N/A
- EPS
- ACB N/A
- MASS N/A
- Revenue
- ACB $262,403,032.00
- MASS $65,560,000.00
- Revenue This Year
- ACB $9.42
- MASS N/A
- Revenue Next Year
- ACB $3.01
- MASS $22.29
- P/E Ratio
- ACB N/A
- MASS N/A
- Revenue Growth
- ACB 28.58
- MASS 37.93
- 52 Week Low
- ACB $3.42
- MASS $1.81
- 52 Week High
- ACB $6.91
- MASS $8.06
- Technical
- Relative Strength Index (RSI)
- ACB 50.53
- MASS 59.36
- Support Level
- ACB $4.87
- MASS $5.52
- Resistance Level
- ACB $5.11
- MASS $5.83
- Average True Range (ATR)
- ACB 0.21
- MASS 0.33
- MACD
- ACB -0.02
- MASS 0.09
- Stochastic Oscillator
- ACB 23.65
- MASS 82.31
About ACB Aurora Cannabis Inc.
Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.